Leukocyte reduction, plasma apheresis, and cytomegalovirus DNA levels in samples

Laboratory Medicine

Volumn 38, Issue 11, 2007, Pages 676-679

  Payne, Deborah ^a   Sower, Laurie ^b   Allison, Paul ^e   Kurosky, Alex ^c   Weems, Justin ^d   Neerman, Michael ^f   Indrikovs, Alexander ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d MAYO CLINIC   (United States)

^e ST LUKE S EPISCOPAL HOSPITAL   (United States)

^f PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPACHROME TAUTOMERASE; HAPTOGLOBIN; VIRUS DNA;

APHERESIS; ARTICLE; BLOOD SAMPLING; CELL SEPARATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKOCYTE COUNT; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; VIRUS LOAD;

CYTOMEGALOVIRUS;

EID: 47149098064     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Foster KM. Post transfusion mononucleosis. Aust Ann Med. 1966;15:305-310.
2. Gallant JE, Moore RD, Richman DD, et al. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis. 1992;166:1223-1227.
3. Fowler KB, Stagna S, Pass RF, et al. The outcome of congenital CMV infection in relation to maternal antibody status. N Eng J Med. 1992;326:663-667.
4. Ballard RA, Drew WL, Hufnagle KG, et al. Acquired cytomegalovirus infection in preterm infants. Am J Dis Child. 1979;133:482-485.
5. Yeager AS, Grumet FC, Halfeigh EB, et al. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr. 1981;98:281-287.
6. Adler SP, Chandrika T, Lawrence L, et al. Cytomegalovirus infections in neonates acquired by blood transfusions. Pediatr Infect Dis. 1983;2:114-118.
7. Bowden RA, Sayers M, Flournoy N, et al. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med. 1986;314:1006-1010.
8. Miller WJ, McCullough J, Balfour HH, et al. Prevention of cytomegalovirus infection following bone marrow transplantation: A randomized trial of blood product screening. Bone Marrow Transplant. 1991;7:227-234.
9. Krajden M, Shankaran P, Bourke C, et al. Detection of CMV in blood donors by PCR using the Digene Sharp system assay: Effects of sample preparation and detection methodology. J Clin Microbiol. 1996;34:29-33.
10. Rubin RH, Tolkoff-Rubin NE, Oliver D. Multicenter seroepidemiologic study of the impact of CMV infection on renal transplantation. Transplantation. 1985;40:243-249.
11. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood. 1995;86:3598-3603.
12. Gilbert GL, Hayes K, Hudson IL, et al. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infectious Study Group. Lancet. 1989;1:1228-1231.
13. Xu D, Yonetani M, Uetani Y, et al. Acquired cytomegalovirus infection and blood in preterm infants. Acta Paediat Jpn. 1995;37:444-449.
14. Soderbergman B, Mocarski ES. Quantitative analysis of latent human cytomegalovirus. J Virol. 1999;73:4806-4812.
15. Reagan KJ, Cabradilla C, Shuman B, et al. Analytical performance of a quantitative CMV DNA detection method. In CMV-related Immunopathology. Scholz M, Rabenau HF, Doerr HW, et al, eds. Monogr Virol. Basel, Karger, 1998;21:252-261.
16. Boivin G, Handfield J, Murray G, et al. Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the SHARP Signal Detection System. J Clin Micro. 1997;35:525-526.
17. van der Meer JT, Drew WL, Bowden RA, et al. Summary of the International Consensus Symposium on advances in the diagnosis, treatment, and prophylaxis and CMV infection. Antiviral Res. 1996;32:119-140.
18. Grazia Revello M, Zavattoni M, Sarasini A, et al. Prenatal diagnostic and prognostic value of human cytomegalovirus load and IgM antibody response in blood of congenitally infected fetuses. J Infect Dis. 1999;180:1320-1323.
19. Jabs DA, Forman M, Enger C, et al. Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group. J Clin Microbiol. 1999;37:1431-1435.
20. Boeckh M, Gallez-Hawkins GM, Myerson D, et al. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: Comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplantation. 1997;64:108-113.
21. Revello MG, Zatattoni M, Sarasini A, et al. Human cytomegalovirus in blood of immunocompetent persons during primary infection: Prognostic implications for pregnancy. J Infectious Disease. 1998;177:1170-1175.
22. Revello MG, Zavattoni M, Sarasini A, et al. Prenatal diagnostic and prognostic value of human cytomegalovirus load and IgM antibody response in blood of congenitally infected fetuses. J Infect Disease. 1999;180:702.
23. Limaye AP, Huang ML, Leisenring W, et al. Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients. J Infect Dis. 2001;183:377-382.
24. Roback JD, Hillyer CD, Drew WL, et al. Multicentered evaluation of PCR methods for detecting CMV DNA in blood donors. Transfusion. 2001;41:1249-1257.
25. Blajchman MA. The clinical benefits of the leukoreduction of blood products. J Trauma. 2006;60:S83-S90.
26. Paradowska E, Przepiorkiewicz M, Nowakowska D, et al. Detection of cytomegalovirus in human placental cells by polymerase chain reaction. Acta Pathologica Microbiologica et Immunologica Scandinavica (APMIS). 2006;114:764-771.
27. Djupesland G, Berdal P, Johannessen TA, et al. Viral infection as a cause of acute peripheral facial palsy. Arch Otolaryngol. 1976;102:403-406.
28. Koch W, Latz W, Eichinger M, et al. Haptoglobin gene subtyping by restriction enzyme analysis. Clin Chem. 2003;49:1937-1939.
29. Baumann MA, Hanson GA, Reed KD, et al. Massive intravascular hemolysis without serum haptoglobin depletion. Hum Pathol. 1985;16:1275-1277.
30. Orita M, Yamamoto S, Katayama N, et al. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors. Curr Pharm Des. 2002;8:1297-317.
31. Visconti MR, Pennington J, Garner SF, et al. Assessment of removal of human cytomegalovirus from blood components by leukocyte depletion filters using real-time quantitative PCR. Blood. 2004;103:1137-1139. Epub Oct 2 2003.
32. Dumont LJ, Luka J, VandenBroeke T, et al. The effect of leukocyte-reduction method on the amount of human cytomegalovirus in blood products: Comparison of apheresis and filtration methods. Blood. 2001;97:3640-3647.